As of June 30, 2026, Roche Holding Ltd CAD Hedged CIBC CDR carries a market capitalization of 452.24B, placing it among publicly traded companies globally. Its enterprise value stands at 498.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 452.24B |
| Enterprise Value | 498.08B |
As of June 30, 2026, Roche Holding Ltd CAD Hedged CIBC CDR has 17.57B shares outstanding.
| Shares Outstanding | 17.57B |
These figures are as of June 30, 2026.
| PB Ratio | 7.87 |
| P/TBV Ratio | 45.93 |
As of June 30, 2026, Roche Holding Ltd CAD Hedged CIBC CDR maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.23 |
| Quick Ratio | 0.34 |
| Debt / Equity | 86.62 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 112,774.00 |
As of the close on October 22, 2026, Roche Holding Ltd CAD Hedged CIBC CDR's stock has gained approximately 40.45% over the past 52 weeks.
| 52-Week Price Change | 40.45% |
As of June 30, 2026, Roche Holding Ltd CAD Hedged CIBC CDR holds 17.10B in cash and equivalents against 55.88B in total debt, resulting in a net debt position of 46.30B. Total book value stands at 57.44B, with working capital of 11.58B providing operational flexibility.
| Cash & Cash Equivalents | 17.10B |
| Total Debt | 55.88B |
| Net Debt | 46.30B |
| Equity (Book Value) | 57.44B |
| Book Value Per Share | 3.27 |
| Working Capital | 11.58B |
Already premium?